 <h1>Desirudin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to desirudin: parenteral powder for injection</i></p><h3>Warning</h3><p><ul>
<b>Spinal/Epidural Hematoma Risk</b>
<li>
Risk of epidural or spinal hematomas and neurologic injury, including long-term or permanent paralysis, associated with concurrent use of selective thrombin inhibitors and neuraxial (spinal/epidural) anesthesia or spinal puncture.&lt;sup&gt;1&lt;/sup&gt;</li></ul></p><ul>
<b>Spinal/Epidural Hematoma Risk</b>
<li>
Risk of epidural or spinal hematomas and neurologic injury, including long-term or permanent paralysis, associated with concurrent use of selective thrombin inhibitors and neuraxial (spinal/epidural) anesthesia or spinal puncture.&lt;sup&gt;1&lt;/sup&gt;</li></ul><p>
<li>
Risk increased by use of indwelling epidural catheters for administration of analgesia or by concomitant use of drugs affecting hemostasis (e.g., NSAIAs, platelet aggregation inhibitors, other anticoagulants).&lt;sup&gt;1&lt;/sup&gt;</li></p><p>
<li>
Risk also increased by traumatic or repeated epidural or spinal puncture.&lt;sup&gt;1&lt;/sup&gt;</li></p><p>
<li>
Monitor frequently for signs and symptoms of neurologic impairment and treat urgently if neurologic compromise noted.&lt;sup&gt;1&lt;/sup&gt;</li></p><p>
<li>
Consider potential benefits versus risks of spinal or epidural anesthesia or spinal puncture in patients receiving or being considered for thromboprophylaxis with anticoagulants. &lt;sup&gt;1&lt;/sup&gt; (See Hemorrhagic Effects and also see Neurologic Effects under Cautions.)</li></p><p></p><p>Side effects include:</p><p>Hemorrhage, including hematoma, was most common adverse effect in clinical studies in patients undergoing elective total hip-replacement surgery. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to desirudin: subcutaneous powder for injection</i></p><h3>General</h3><p>The most common adverse reaction was hemorrhage.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Any hemorrhage (30%)</p><p><b>Common</b> (1% to 10%): Serious hemorrhage, deep vein thrombosis</p><p><b>Uncommon</b> (0.1% to 1%): Major hemorrhage</p><p><b>Frequency not reported</b>: Thrombosis, hypotension</p><p><b>Postmarketing reports</b>: Fatal hemorrhage<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Wound secretion</p><p><b>Frequency not reported</b>: Leg edema, fever, healing impaired<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p><p><b>Frequency not reported</b>: Vomiting, hematemesis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p><p><b>Frequency not reported</b>: Hemoglobin decreased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Irritative skin reactions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site mass<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Allergic reaction, anti-hirudin antibodies</p><p><b>Postmarketing reports</b>: Anaphylactic/anaphylactoid reaction<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Dizziness, cerebrovascular disorder<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Leg pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Epistaxis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Ipravask (desirudin)." Aventis Pharmaceuticals, Swiftwater, PA. </p><h2>More about desirudin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: thrombin inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Desirudin Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Deep Vein Thrombosis, Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>